Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 345

1.

Calreticulin overexpression correlates with integrin-α5 and transforming growth factor-β1 expression in the atria of patients with rheumatic valvular disease and atrial fibrillation.

Zhao F, Zhang S, Shao Y, Wu Y, Qin J, Chen Y, Chen L, Gu H, Wang X, Huang C, Zhang W.

Int J Cardiol. 2013 Oct 3;168(3):2177-85. doi: 10.1016/j.ijcard.2013.01.239.

PMID:
23465222
2.

Calcium- and integrin-binding protein-1 and calcineurin are upregulated in the right atrial myocardium of patients with atrial fibrillation.

Zhao F, Zhang S, Chen L, Wu Y, Qin J, Shao Y, Wang X, Chen Y.

Europace. 2012 Dec;14(12):1726-33. doi: 10.1093/europace/eus149.

PMID:
22547769
3.

Atrial fibrillation in pure rheumatic mitral valvular disease is expression of an atrial histological change.

Alessandri N, Tufano F, Petrassi M, Alessandri C, Di Cristofano C, Della Rocca C, Gallo P.

Eur Rev Med Pharmacol Sci. 2009 Nov-Dec;13(6):431-42.

PMID:
20085124
4.

Increased expression of NF-AT3 and NF-AT4 in the atria correlates with procollagen I carboxyl terminal peptide and TGF-β1 levels in serum of patients with atrial fibrillation.

Zhao F, Zhang S, Chen Y, Gu W, Ni B, Shao Y, Wu Y, Qin J.

BMC Cardiovasc Disord. 2014 Nov 25;14:167. doi: 10.1186/1471-2261-14-167.

5.

Increased TRPM6 expression in atrial fibrillation patients contribute to atrial fibrosis.

Zhang YJ, Ma N, Su F, Liu H, Mei J.

Exp Mol Pathol. 2015 Jun;98(3):486-90. doi: 10.1016/j.yexmp.2015.03.025.

PMID:
25796343
6.

Angiotensin II receptor type 1 is upregulated in atrial tissue of patients with rheumatic valvular disease with atrial fibrillation.

Cong H, Li X, Ma L, Jiang H, Mao Y, Xu M.

J Thorac Cardiovasc Surg. 2010 Aug;140(2):298-304. doi: 10.1016/j.jtcvs.2009.10.035.

7.

Role of the MAPKs/TGF-β1/TRAF6 signaling pathway in atrial fibrosis of patients with chronic atrial fibrillation and rheumatic mitral valve disease.

Zhang D, Liu X, Chen X, Gu J, Li F, Zhang W, Zheng Y.

Cardiology. 2014;129(4):216-23. doi: 10.1159/000366096.

PMID:
25376239
8.

Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation.

Gaborit N, Steenman M, Lamirault G, Le Meur N, Le Bouter S, Lande G, Léger J, Charpentier F, Christ T, Dobrev D, Escande D, Nattel S, Demolombe S.

Circulation. 2005 Jul 26;112(4):471-81.

9.

Gene expression profile associated with chronic atrial fibrillation and underlying valvular heart disease in man.

Lamirault G, Gaborit N, Le Meur N, Chevalier C, Lande G, Demolombe S, Escande D, Nattel S, Léger JJ, Steenman M.

J Mol Cell Cardiol. 2006 Jan;40(1):173-84.

PMID:
16242148
10.

TGF-β1 and TIMP-4 regulate atrial fibrosis in atrial fibrillation secondary to rheumatic heart disease.

Sun Y, Huang ZY, Wang ZH, Li CP, Meng XL, Zhang YJ, Su F, Ma N.

Mol Cell Biochem. 2015 Aug;406(1-2):131-8. doi: 10.1007/s11010-015-2431-1.

PMID:
25971370
11.

[Changes in gelatinases expression and activity in human atria during atrial fibrillation].

Ke D, Xu CX, Zhang JC, Chen L, Lin YZ, Lin LF, Hu XZ.

Zhonghua Xin Xue Guan Bing Za Zhi. 2005 Feb;33(2):137-42. Chinese.

PMID:
15924808
13.

[Effect of hepatocyte growth factor and transforming growth factor-β(1) on atrial fibroblasts fibrosis].

Zhang JC, Chen JQ, Xu CX, Chen L, Lin YZ, Wu GS.

Zhonghua Xin Xue Guan Bing Za Zhi. 2012 Oct;40(10):834-9. Chinese.

PMID:
23302670
14.

Alterations in cardiac sarcoplasmic reticulum Ca2+ regulatory proteins in the atrial tissue of patients with chronic atrial fibrillation.

Ohkusa T, Ueyama T, Yamada J, Yano M, Fujumura Y, Esato K, Matsuzaki M.

J Am Coll Cardiol. 1999 Jul;34(1):255-63.

15.

Up-regulation of inositol 1,4,5 trisphosphate receptor expression in atrial tissue in patients with chronic atrial fibrillation.

Yamda J, Ohkusa T, Nao T, Ueyama T, Yano M, Kobayashi S, Hamano K, Esato K, Matsuzaki M.

J Am Coll Cardiol. 2001 Mar 15;37(4):1111-9.

16.

Increased expression of connective tissue growth factor and transforming growth factor-beta-1 in atrial myocardium of patients with chronic atrial fibrillation.

Li Y, Jian Z, Yang ZY, Chen L, Wang XF, Ma RY, Xiao YB.

Cardiology. 2013;124(4):233-40. doi: 10.1159/000347126.

PMID:
23571482
17.

[Relationship between atrial fibroblast proliferation/fibrosis and atrial fibrillation in patients with rheumatic heart disease].

Lin YZ, Cai JM, Chen L, Yang ZP, Zhang JC, Wu W, Ke D, Xu CX.

Zhonghua Xin Xue Guan Bing Za Zhi. 2009 Sep;37(9):813-7. Chinese.

PMID:
20128380
18.

TGF-beta1 expression and atrial myocardium fibrosis increase in atrial fibrillation secondary to rheumatic heart disease.

Xiao H, Lei H, Qin S, Ma K, Wang X.

Clin Cardiol. 2010 Mar;33(3):149-56. doi: 10.1002/clc.20713.

19.

[Rheumatic valvular surgery and concomitant radiofrequency Maze procedure: TGF-β1 mRNA expression predicting the efficacy].

Li Y, Wang X, Liu L, Liu YX, Wang W, Hu SS.

Zhonghua Wai Ke Za Zhi. 2010 Jun 1;48(11):820-4. Chinese.

PMID:
21163049
20.

Plasma transforming growth factor beta1 as a biochemical marker to predict the persistence of atrial fibrillation after the surgical maze procedure.

On YK, Jeon ES, Lee SY, Shin DH, Choi JO, Sung J, Kim JS, Sung K, Park P.

J Thorac Cardiovasc Surg. 2009 Jun;137(6):1515-20. doi: 10.1016/j.jtcvs.2008.10.022.

Supplemental Content

Support Center